ClinicalTrials.Veeva

Menu
A

Atlanta Behavioral Research, LLC | Atlanta, GA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Esketamine
SEP-4199
Cariprazine
NMRA-335140
Centanafadine
JNJ-67953964
Levomilnacipran
SEP-363856
BTRX-335140
54135419SUI3002

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 15 total trials

Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

The purpose of this study is to evaluate the efficacy and safety of cariprazine in the treatment of schizophrenia in the adolescent population.

Enrolling
Schizophrenia
Drug: Cariprazine
Drug: Placebo

This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophren...

Enrolling
Autism Spectrum Disorder
Schizophrenia
Drug: Lumateperone

Trial sponsors

Janssen (J&J Innovative Medicine) logo
Otsuka logo
Sumitomo Pharma logo
Allergan logo
E
G
Intra-Cellular Therapies logo
L
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems